EP3445786
DIAGNOSIS OF IMMUNE ACTIVATION USING CLEVER-1, TNF-ALPHA AND HLA-DR BINDING AGENTS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
18.4.2017EP published:
4.10.2023EP application number:
17722487.0
EPO information:
European Patent Register
Max expiry date:
17.4.2037
Title in English:
DIAGNOSIS OF IMMUNE ACTIVATION USING CLEVER-1, TNF-ALPHA AND HLA-DR BINDING AGENTSLanguage of the patent:
English
Timeline
Today
18.4.2017EP application
4.10.2023EP Publication
Owner
Name:
Faron Pharmaceuticals OYAddress:
Joukahaisenkatu 6, 20520 Turku, FI
Inventor
Name:
HOLLMÉN, Maija-LeenaAddress:
20760 Piispanristi, FI
Name:
VIITALA, MiroAddress:
20520 Turku, FI
Name:
JALKANEN, MarkkuAddress:
20760 Piispanristi, FI
Name:
MAKSIMOW, MikaelAddress:
20900 Turku, FI
Priority
Number:
20165336Date:
18.4.2016Country:
FI
Classification
Categories:
A61K 39/00, A61P 35/00, A61P 37/04, C07K 16/28, G01N 33/50, G01N 33/68